+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Migraine Drugs Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • October 2022
  • Region: Global
  • TechNavio
  • ID: 5681552
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the migraine drugs market and it is poised to grow by $1 bn during 2022-2026, accelerating at a CAGR of 5.74% during the forecast period. This report on the migraine drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

This report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in number of patients suffering from migraine, the advent of regenerative medicines, and rising advances in migraine drugs.

The migraine drugs market analysis includes the end-user and type segments and geographic landscape.

The publisher's migraine drugs market is segmented as below:

By End-user

  • Hospitals
  • Retail
  • Online

By Type

  • Preventive
  • Abortive

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growth in the number of migraine treatment awareness programs as one of the prime reasons driving the migraine drugs market growth during the next few years. Also, an increase in the availability of late-stage pipeline products and drug reformulations will lead to sizable demand in the market.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters. This report on the migraine drugs market covers the following areas:
  • Migraine drugs market sizing
  • Migraine drugs market forecast
  • Migraine drugs market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading migraine drugs market vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, H Lundbeck AS, Johnson and Johnson, Merck and Co. Inc., Neurelis Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Sanofi SA, Winston Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., GlaxoSmithKline Plc, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. Also, the migraine drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
  • Exhibit 13: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
  • Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
  • Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
  • Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
  • Exhibit 21: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
  • Exhibit 22: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
  • Exhibit 23: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
  • Exhibit 24: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by End-user
5.1 Market segments
  • Exhibit 25: Chart on End-user - Market share 2021-2026 (%)
  • Exhibit 26: Data Table on End-user - Market share 2021-2026 (%)
5.2 Comparison by End-user
  • Exhibit 27: Chart on Comparison by End-user
  • Exhibit 28: Data Table on Comparison by End-user
5.3 Hospitals - Market size and forecast 2021-2026
  • Exhibit 29: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
  • Exhibit 31: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
  • Exhibit 32: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
5.4 Retail - Market size and forecast 2021-2026
  • Exhibit 33: Chart on Retail - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Data Table on Retail - Market size and forecast 2021-2026 ($ million)
  • Exhibit 35: Chart on Retail - Year-over-year growth 2021-2026 (%)
  • Exhibit 36: Data Table on Retail - Year-over-year growth 2021-2026 (%)
5.5 Online - Market size and forecast 2021-2026
  • Exhibit 37: Chart on Online - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Data Table on Online - Market size and forecast 2021-2026 ($ million)
  • Exhibit 39: Chart on Online - Year-over-year growth 2021-2026 (%)
  • Exhibit 40: Data Table on Online - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by End-user
  • Exhibit 41: Market opportunity by End-user ($ million)
6 Market Segmentation by Type
6.1 Market segments
  • Exhibit 42: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 43: Data Table on Type - Market share 2021-2026 (%)
6.2 Comparison by Type
  • Exhibit 44: Chart on Comparison by Type
  • Exhibit 45: Data Table on Comparison by Type
6.3 Preventive - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Preventive - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Preventive - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Preventive - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Preventive - Year-over-year growth 2021-2026 (%)
6.4 Abortive - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Abortive - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Abortive - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Abortive - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Abortive - Year-over-year growth 2021-2026 (%)
6.5 Market opportunity by Type
  • Exhibit 54: Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
  • Exhibit 55: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
  • Exhibit 56: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 57: Data Table on Market share By Geographical Landscape 2021-2026 (%)
8.2 Geographic comparison
  • Exhibit 58: Chart on Geographic comparison
  • Exhibit 59: Data Table on Geographic comparison
8.3 North America - Market size and forecast 2021-2026
  • Exhibit 60: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 61: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 62: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 63: Data Table on North America - Year-over-year growth 2021-2026 (%)
8.4 Europe - Market size and forecast 2021-2026
  • Exhibit 64: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 65: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 66: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 67: Data Table on Europe - Year-over-year growth 2021-2026 (%)
8.5 Asia - Market size and forecast 2021-2026
  • Exhibit 68: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 69: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 70: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 71: Data Table on Asia - Year-over-year growth 2021-2026 (%)
8.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 72: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 73: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 74: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 75: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
8.7 US - Market size and forecast 2021-2026
  • Exhibit 76: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 77: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 78: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 79: Data Table on US - Year-over-year growth 2021-2026 (%)
8.8 Germany - Market size and forecast 2021-2026
  • Exhibit 80: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 81: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 82: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 83: Data Table on Germany - Year-over-year growth 2021-2026 (%)
8.9 Canada - Market size and forecast 2021-2026
  • Exhibit 84: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 85: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 86: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 87: Data Table on Canada - Year-over-year growth 2021-2026 (%)
8.10 China - Market size and forecast 2021-2026
  • Exhibit 88: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 89: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 90: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 91: Data Table on China - Year-over-year growth 2021-2026 (%)
8.11 Japan - Market size and forecast 2021-2026
  • Exhibit 92: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 93: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 94: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 95: Data Table on Japan - Year-over-year growth 2021-2026 (%)
8.12 Republic of Korea - Market size and forecast 2021-2026
  • Exhibit 96: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
  • Exhibit 97: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
  • Exhibit 98: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
  • Exhibit 99: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
8.13 Market opportunity By Geographical Landscape
  • Exhibit 100: Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2021 and 2026
9.4 Market trends
10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
10.4 Industry risks
  • Exhibit 104: Impact of key risks on business
11 Vendor Analysis
11.1 Vendors covered
  • Exhibit 105: Vendors covered
11.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
11.3 Amgen Inc.
  • Exhibit 107: Amgen Inc. - Overview
  • Exhibit 108: Amgen Inc. - Product/Service
  • Exhibit 109: Amgen Inc. - Key offerings
11.4 AstraZeneca Plc
  • Exhibit 110: AstraZeneca Plc - Overview
  • Exhibit 111: AstraZeneca Plc - Product/Service
  • Exhibit 112: AstraZeneca Plc - Key news
  • Exhibit 113: AstraZeneca Plc - Key offerings
11.5 Eli Lilly and Co.
  • Exhibit 114: Eli Lilly and Co. - Overview
  • Exhibit 115: Eli Lilly and Co. - Product/Service
  • Exhibit 116: Eli Lilly and Co. - Key offerings
11.6 Endo International Plc
  • Exhibit 117: Endo International Plc - Overview
  • Exhibit 118: Endo International Plc - Business segments
  • Exhibit 119: Endo International Plc - Key news
  • Exhibit 120: Endo International Plc - Key offerings
  • Exhibit 121: Endo International Plc - Segment focus
11.7 GlaxoSmithKline Plc
  • Exhibit 122: GlaxoSmithKline Plc - Overview
  • Exhibit 123: GlaxoSmithKline Plc - Business segments
  • Exhibit 124: GlaxoSmithKline Plc - Key offerings
  • Exhibit 125: GlaxoSmithKline Plc - Segment focus
11.8 H Lundbeck AS
  • Exhibit 126: H Lundbeck AS - Overview
  • Exhibit 127: H Lundbeck AS - Product/Service
  • Exhibit 128: H Lundbeck AS - Key offerings
11.9 Merck and Co. Inc.
  • Exhibit 129: Merck and Co. Inc. - Overview
  • Exhibit 130: Merck and Co. Inc. - Business segments
  • Exhibit 131: Merck and Co. Inc. - Key news
  • Exhibit 132: Merck and Co. Inc. - Key offerings
  • Exhibit 133: Merck and Co. Inc. - Segment focus
11.10 Otsuka Pharmaceutical Co. Ltd.
  • Exhibit 134: Otsuka Pharmaceutical Co. Ltd. - Overview
  • Exhibit 135: Otsuka Pharmaceutical Co. Ltd. - Product/Service
  • Exhibit 136: Otsuka Pharmaceutical Co. Ltd. - Key offerings
11.11 Pfizer Inc.
  • Exhibit 137: Pfizer Inc. - Overview
  • Exhibit 138: Pfizer Inc. - Product/Service
  • Exhibit 139: Pfizer Inc. - Key news
  • Exhibit 140: Pfizer Inc. - Key offerings
11.12 Teva Pharmaceutical Industries Ltd.
  • Exhibit 141: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 142: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 143: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 144: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 145: Teva Pharmaceutical Industries Ltd. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
  • Exhibit 146: Inclusions checklist
  • Exhibit 147: Exclusions checklist
12.3 Currency conversion rates for US$
  • Exhibit 148: Currency conversion rates for US$
12.4 Research methodology
  • Exhibit 149: Research methodology
  • Exhibit 150: Validation techniques employed for market sizing
  • Exhibit 151: Information sources
12.5 List of abbreviations
  • Exhibit 152: List of abbreviations
  • health: Includes veterinary drugs (excluded from the scope of the report)
Exhibits:
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibit 21: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibit 22: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibit 23: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibit 24: Chart on Market condition - Five forces 2021 and 2026
Exhibit 25: Chart on End-user - Market share 2021-2026 (%)
Exhibit 26: Data Table on End-user - Market share 2021-2026 (%)
Exhibit 27: Chart on Comparison by End-user
Exhibit 28: Data Table on Comparison by End-user
Exhibit 29: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
Exhibit 31: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
Exhibit 32: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
Exhibit 33: Chart on Retail - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Data Table on Retail - Market size and forecast 2021-2026 ($ million)
Exhibit 35: Chart on Retail - Year-over-year growth 2021-2026 (%)
Exhibit 36: Data Table on Retail - Year-over-year growth 2021-2026 (%)
Exhibit 37: Chart on Online - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Data Table on Online - Market size and forecast 2021-2026 ($ million)
Exhibit 39: Chart on Online - Year-over-year growth 2021-2026 (%)
Exhibit 40: Data Table on Online - Year-over-year growth 2021-2026 (%)
Exhibit 41: Market opportunity by End-user ($ million)
Exhibit 42: Chart on Type - Market share 2021-2026 (%)
Exhibit 43: Data Table on Type - Market share 2021-2026 (%)
Exhibit 44: Chart on Comparison by Type
Exhibit 45: Data Table on Comparison by Type
Exhibit 46: Chart on Preventive - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Preventive - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Preventive - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Preventive - Year-over-year growth 2021-2026 (%)
Exhibit 50: Chart on Abortive - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Abortive - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Abortive - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Abortive - Year-over-year growth 2021-2026 (%)
Exhibit 54: Market opportunity by Type ($ million)
Exhibit 55: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 56: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 57: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 58: Chart on Geographic comparison
Exhibit 59: Data Table on Geographic comparison
Exhibit 60: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 61: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 62: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 63: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibit 64: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 65: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 66: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 67: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 68: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 69: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 70: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 71: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 72: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 73: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 74: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 75: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 76: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 77: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 78: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 79: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibit 80: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 81: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 82: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 83: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 84: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 85: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 86: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 87: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 88: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 89: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 90: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 91: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibit 92: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 93: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 94: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 95: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 96: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibit 97: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibit 98: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibit 99: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibit 100: Market opportunity By Geographical Landscape ($ million)
Exhibit 101: Impact of drivers and challenges in 2021 and 2026
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
Exhibit 103: Overview on factors of disruption
Exhibit 104: Impact of key risks on business
Exhibit 105: Vendors covered
Exhibit 106: Matrix on vendor position and classification
Exhibit 107: Amgen Inc. - Overview
Exhibit 108: Amgen Inc. - Product/Service
Exhibit 109: Amgen Inc. - Key offerings
Exhibit 110: AstraZeneca Plc - Overview
Exhibit 111: AstraZeneca Plc - Product/Service
Exhibit 112: AstraZeneca Plc - Key news
Exhibit 113: AstraZeneca Plc - Key offerings
Exhibit 114: Eli Lilly and Co. - Overview
Exhibit 115: Eli Lilly and Co. - Product/Service
Exhibit 116: Eli Lilly and Co. - Key offerings
Exhibit 117: Endo International Plc - Overview
Exhibit 118: Endo International Plc - Business segments
Exhibit 119: Endo International Plc - Key news
Exhibit 120: Endo International Plc - Key offerings
Exhibit 121: Endo International Plc - Segment focus
Exhibit 122: GlaxoSmithKline Plc - Overview
Exhibit 123: GlaxoSmithKline Plc - Business segments
Exhibit 124: GlaxoSmithKline Plc - Key offerings
Exhibit 125: GlaxoSmithKline Plc - Segment focus
Exhibit 126: H Lundbeck AS - Overview
Exhibit 127: H Lundbeck AS - Product/Service
Exhibit 128: H Lundbeck AS - Key offerings
Exhibit 129: Merck and Co. Inc. - Overview
Exhibit 130: Merck and Co. Inc. - Business segments
Exhibit 131: Merck and Co. Inc. - Key news
Exhibit 132: Merck and Co. Inc. - Key offerings
Exhibit 133: Merck and Co. Inc. - Segment focus
Exhibit 134: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibit 135: Otsuka Pharmaceutical Co. Ltd. - Product/Service
Exhibit 136: Otsuka Pharmaceutical Co. Ltd. - Key offerings
Exhibit 137: Pfizer Inc. - Overview
Exhibit 138: Pfizer Inc. - Product/Service
Exhibit 139: Pfizer Inc. - Key news
Exhibit 140: Pfizer Inc. - Key offerings
Exhibit 141: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 142: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 143: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 144: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 145: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 146: Inclusions checklist
Exhibit 147: Exclusions checklist
Exhibit 148: Currency conversion rates for US$
Exhibit 149: Research methodology
Exhibit 150: Validation techniques employed for market sizing
Exhibit 151: Information sources
Exhibit 152: List of abbreviations

Executive Summary

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes the publisher's platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Dr Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • Endo International Plc
  • H Lundbeck AS
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Neurelis Inc.
  • Novartis AG
  • Otsuka Pharmaceutical Co. Ltd.
  • Sanofi SA
  • Winston Pharmaceuticals Ltd.
  • Amneal Pharmaceuticals Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.